Sesamin Enhances Nrf2-Mediated Protective Defense against Oxidative Stress and Inflammation in Colitis via AKT and ERK Activation
Open Access
- 26 August 2019
- journal article
- retracted article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-20
Abstract
Ulcerative colitis (UC) is a major form of inflammatory bowel disease (IBD) with high incidence and prevalence in many countries. Patients with UC usually suffer from a lifetime of debilitating physical symptoms. Therefore, developing effective therapeutic strategy that can manage this disease better and improve patients’ life quality is in urgent need. Sesamin (SSM) is a lignan derived from sesame seeds. In this study, the protective effect of SSM against UC and the underlying mechanism were investigated in vitro and in vivo. Our data showed that SSM protected Caco-2 cells from H2O2-induced oxidative stress injury via GSH-mediated scavenging of reactive oxygen species (ROS). Dual luciferase reporter assay showed that the transcriptional activity of nuclear factor erythroid-related factor 2 (Nrf2) was significantly increased by SSM, and the ability of SSM to activate Nrf2-targeted genes was further confirmed in Caco-2 cells using western blot and quantitative real-time PCR (qRT-PCR). In contrast, Nrf2 knockdown abolished the protective effect of SSM. Additionally, we found that SSM also activated advanced protein kinase B (AKT) and extracellular signal-regulated kinase (ERK) in Caco-2 cells, while either AKT or ERK inhibition can prevent SSM-mediated nuclear translocation of Nrf2. Furthermore, SSM displayed a better protective effect against dextran sulfate sodium- (DSS-) induced UC compared with 5-aminosalicylic acid (5-ASA) in C57BL/6 mice. The enhanced Nrf2 signaling and activated AKT/ERK were also observed in the colon of mice after SSM administration. These results first demonstrate the protective effect of SSM against UC and indicate that the effect is associated with AKT/ERK activation and subsequent Nrf2 signaling enhancement. This study provides a new insight into the medicinal value of SSM and proposes it as a new natural nutrition for better managing the symptoms of UC.Keywords
Funding Information
- Guangdong Provincial Key Laboratory of Construction Foundation (2017B030314030, 2011A060901014, 81102886, 81573658)
- Guangdong Provincial Key Laboratory of Construction Foundation (2017B030314030, 2011A060901014, 81102886, 81573658)
- National Natural Science Foundation of China (2017B030314030, 2011A060901014, 81102886, 81573658)
- National Natural Science Foundation of China (2017B030314030, 2011A060901014, 81102886, 81573658)
This publication has 42 references indexed in Scilit:
- Enzymatically synthesized glycogen inhibits colitis through decreasing oxidative stressFree Radical Biology and Medicine, 2017
- Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transportersDrug Metabolism Reviews, 2016
- Oxidative Stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal CancerOxidative Medicine and Cellular Longevity, 2015
- Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?Redox Biology, 2015
- The complexity of the Nrf2 pathway: beyond the antioxidant responseThe Journal of Nutritional Biochemistry, 2015
- Essential role of PH domain and leucine-rich repeat protein phosphatase 2 in Nrf2 suppression via modulation of Akt/GSK3β/Fyn kinase axis during oxidative hepatocellular toxicityCell Death & Disease, 2014
- The Ras GTPase-activating-like Protein IQGAP1 Mediates Nrf2 Protein Activation via the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (ERK) Kinase (MEK)-ERK PathwayJournal of Biological Chemistry, 2013
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic ReviewGastroenterology, 2012
- Ulcerative ColitisNew England Journal of Medicine, 2011
- Oxidative stress as a pathogenic factor in inflammatory bowel disease — radicals or ridiculous?Alimentary Pharmacology & Therapeutics, 2002